169 related articles for article (PubMed ID: 8787245)
21. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
22. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
23. Excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic acid-sensitive chloride channels.
Babot Z; Cristòfol R; Suñol C
Eur J Neurosci; 2005 Jan; 21(1):103-12. PubMed ID: 15654847
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of parvalbumin on excitotoxic motor neuron death.
Van Den Bosch L; Schwaller B; Vleminckx V; Meijers B; Stork S; Ruehlicke T; Van Houtte E; Klaassen H; Celio MR; Missiaen L; Robberecht W; Berchtold MW
Exp Neurol; 2002 Apr; 174(2):150-61. PubMed ID: 11922657
[TBL] [Abstract][Full Text] [Related]
25. Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis.
Iwasaki Y; Ikeda K; Kinoshita M
Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):511-8. PubMed ID: 12769603
[TBL] [Abstract][Full Text] [Related]
26. [Etiological drug therapy for amyotrophic lateral sclerosis].
Cintas P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
[TBL] [Abstract][Full Text] [Related]
27. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.
Yi JH; Hazell AS
Neurochem Int; 2006 Apr; 48(5):394-403. PubMed ID: 16473439
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
Sen I; Nalini A; Joshi NB; Joshi PG
J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
[TBL] [Abstract][Full Text] [Related]
29. [Amyotrophic lateral sclerosis].
Moriwaka F
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):21-5. PubMed ID: 9086359
[TBL] [Abstract][Full Text] [Related]
30. Rethinking a drug treatment failure on a traditional ALS target.
Maragakis NJ
Exp Neurol; 2009 Apr; 216(2):254-7. PubMed ID: 19309797
[TBL] [Abstract][Full Text] [Related]
31. Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord.
Brunet N; Tarabal O; Esquerda JE; Calderó J
J Comp Neurol; 2009 Oct; 516(4):277-90. PubMed ID: 19634179
[TBL] [Abstract][Full Text] [Related]
32. Glutamate alteration of glutamic acid decarboxylase (GAD) in GABAergic neurons: the role of cysteine proteases.
Monnerie H; Le Roux PD
Exp Neurol; 2008 Sep; 213(1):145-53. PubMed ID: 18599042
[TBL] [Abstract][Full Text] [Related]
33. Glutamate, excitotoxicity and amyotrophic lateral sclerosis.
Shaw PJ; Ince PG
J Neurol; 1997 May; 244 Suppl 2():S3-14. PubMed ID: 9178165
[TBL] [Abstract][Full Text] [Related]
34. [Pathogenic mechanisms of neurodegenerative diseases: amyotrophic lateral sclerosis].
Kato AC; Vingerhoets FJ; Magistris MR; Kuntzer T; Burkhard PR
Rev Med Suisse; 2006 May; 2(64):1152-4, 1156-7. PubMed ID: 16734186
[TBL] [Abstract][Full Text] [Related]
35. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.
Cutler RG; Pedersen WA; Camandola S; Rothstein JD; Mattson MP
Ann Neurol; 2002 Oct; 52(4):448-57. PubMed ID: 12325074
[TBL] [Abstract][Full Text] [Related]
36. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
Van den Bosch L
Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
[TBL] [Abstract][Full Text] [Related]
37. Excitotoxins and amyotrophic lateral sclerosis.
Munsat TL; Hollander D
Therapie; 1990; 45(3):277-9. PubMed ID: 2194313
[TBL] [Abstract][Full Text] [Related]
38. Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis.
al-Chalabi A; Powell JF; Leigh PN
Muscle Nerve; 1995 May; 18(5):540-5. PubMed ID: 7739643
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of riluzole in ALS CSF toxicity.
Couratier P; Sindou P; Esclaire F; Louvel E; Hugon J
Neuroreport; 1994 Apr; 5(8):1012-4. PubMed ID: 8061281
[TBL] [Abstract][Full Text] [Related]
40. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism].
Niebroj-Dobosz I; Janik P; Mickielewicz A; Jamrozik Z; Kwieciński H
Neurol Neurochir Pol; 2001; 35(1 Suppl):81-9. PubMed ID: 11732283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
